Posts
Vanda Pharmaceuticals: Cash Is Running Out Faster Than The Launches
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: VNDA Only the headline is available; the article body is paywalled.
Verastem: A Real Pancreatic Cancer Drug, Arriving Second
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: VSTM Only the headline is available; the article body is paywalled.
MeiraGTx: The Data Held Up, The Valuation Didn't (Rating Downgrade)
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: MGTX Only the headline is available; the article body is paywalled.
Krystal Biotech: Vyjuvek's Success Is Becoming Its Growth Problem (Downgrade)
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: KRYS Only the headline is available; the article body is paywalled.
argenx: The Sjögren's Selloff Looks Overdone
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: ARGX Only the headline is available; the article body is paywalled.
Palantir: Great Business, No Margin Of Safety
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: PLTR Only the headline is available; the article body is paywalled.
Ginkgo Bioworks: The Valuation Has Outrun The Business
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: DNA Only the headline is available; the article body is paywalled.
MARA Holdings: Priced For An AI Story It Hasn't Signed Yet
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: MARA Only the headline is available; the article body is paywalled.
Gilead: Buying Growth Isn't Free, And The Discounted Cash Flow Model Knows It
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: GILD Only the headline is available; the article body is paywalled.
Arcutis: Every Beat Gets Absorbed By A Shrinking Multiple (Rating Downgrade)
SeekingAlpha article by Stephen Ayers. Tickers tagged by SeekingAlpha: ARQT Only the headline is available; the article body is paywalled.